BiotechTube
Home/Genscript Biotech/Dr. Lily (Lihua) Wang
DL

Dr. Lily (Lihua) Wang

Chief Operating Officer

Genscript Biotech

Therapeutic Areas

OncologyImmunology

Genscript Biotech Pipeline

DrugIndicationPhase
Ciltacabtagene autoleucel (Carvykti)Relapsed/Refractory Multiple MyelomaApproved / Phase 3
LB1901Relapsed/Refractory T-cell LymphomaPhase 1
LB2102Extensive-Stage Small Cell Lung CancerPhase 1
LB1911Pancreatic Cancer, Colorectal CancerPreclinical / Phase 1 (planned)

Leadership Team at Genscript Biotech

DF
Dr. Frank Zhang (Zhang Fangliang)
Founder, Chairman, CEO
DS
Dr. Shuyuan (Brian) Yao
Chief Financial Officer
DL
Dr. Lei (Ray) Wang
SVP, Head of GenScript ProBio
DY
Dr. Ying Huang
CEO of Legend Biotech
View full Genscript Biotech profile